British Islamic Medical Association (BIMA) welcomes the decision of the Royal College of Nursing (RCN) to end its commercial relationship with Teva UK and withdraw Teva’s sponsorship of an upcoming RCN educational event.
Healthcare institutions have a particular responsibility to ensure that their commercial relationships reflect the ethical principles that underpin our professions.
Sponsorship should involve robust due diligence and consideration of human rights, ethical conduct and organisational values.
Where human rights organisations have questioned the negative impact of Teva’s business model on local Palestinian drug companies, BIMA believes that commercial relationships with organisations potentially connected to the conflict deserve serious and transparent scrutiny. Teva has also been accused of inflating drug prices.
We encourage all UK healthcare organisations and professional bodies to apply similarly robust and transparent ethical standards to commercial partnerships, ensuring that the protection of life, human dignity and professional integrity remain at the heart of healthcare.
In August 2026, BIMA hosted a webinar with Global Health BDS for Palestine exploring these concerns in more detail.
The full webinar can be viewed here.